Product Details
KETOROLAC 30MG/mL 1mL SDV 25BX
Manufacturer: Hospira
MFG#: 00409-3795-01
NDC: 00409-3795-01
PID: 418511
25/BX
$335.54
Limited QuantitiesAdditional Information
| Product Name | Ketorolac 30Mg/Ml 1Ml Sdv 25Bx |
| Application | Nonsteroidal Anti-inflammatory Agent |
| Generic Drug Name | Ketorolac Tromethamine, Preservative Free |
| Mechanism of Action | Inhibits COX-1 and COX-2 enzymes, reducing prostaglandin synthesis |
| Strength | 30 mg / mL |
| Type | Intramuscular or Intravenous |
| Volume | 1 mL |
| Administration | Single-dose injection for short-term pain management |
| Onset of Action | Rapid onset within 30 minutes after administration |
| Duration of Action | Analgesic effect lasts approximately 4-6 hours |
| Side Effects | Gastrointestinal bleeding, dizziness, nausea, or renal dysfunction |
| Usage Limit | Not for use longer than 5 consecutive days |
| Packaging | 25 single-dose glass flip-top vials |
| Storage Conditions | Store at 20-25°C (68-77°F); protect from light |
| Indications | Short-term management of moderate to severe acute pain |
Description
Ketorolac 30 mg/mL is a nonsteroidal anti-inflammatory drug (NSAID) available in a single-dose vial designed for injection. It is formulated with ketorolac tromethamine, a potent NSAID indicated for the short-term management of moderate to severe acute pain. This medication is frequently used when analgesia at the opioid level is required, offering an effective alternative for pain relief without the risk of opioid dependency.
Ketorolac works by inhibiting the cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. This mechanism decreases inflammation, alleviates pain, and reduces fever. It is particularly effective for post-operative pain management and other acute painful conditions requiring rapid analgesic intervention.
This product is not intended for long-term use and should not be administered for more than five consecutive days. Prolonged use may increase the risk of gastrointestinal bleeding, ulceration, or renal complications. Its usage is contraindicated in patients with hypersensitivity to NSAIDs, a history of peptic ulcer disease, or significant renal impairment.
Frequently Asked Questions (FAQs)
The cost of KETOROLAC 30MG/mL 1mL SDV 25BX is $$335.54
KETOROLAC 30MG/mL 1mL SDV 25BX is manufactured by Hospira.
You can purchase KETOROLAC 30MG/mL 1mL SDV 25BX on our website at https://preview_supplies.pipelinemedical.com/product/detail/ketorolac-30mg-ml-1ml-sdv-25bx-418511